What Are the Stages of Ovarian Cancer?

This content has been reviewed and approved by

Maurie Markman, MD
Vice President, Clinical Research
MD Anderson Cancer Center
University of Texas
 

Stages of cancer relate to how far the cancer has spread in your body. The higher the stage number, the more widespread is the cancer. These stages are important to determining the type of treatment you will receive.

Following surgical removal of ovarian cancer, a final stage is given.

  • Stage I - means that cancer is found only in one or both of the ovaries. Cancer cells may also be found in abdominal fluid, or ascites (abnormal amount of fluid in the abdomen). The cancer has not spread to other pelvic or abdominal organs, lymph nodes, or sites outside of the abdomen.
  • Stage II - means that cancer is found in the ovaries and has spread to the uterus (womb), the fallopian tubes, or other parts within the pelvis. Cancer cells may also be found in abdominal fluid, or ascites. The cancer has not spread to the upper abdomen, lymph nodes, or sites outside the abdomen.
  • Stage III - indicates cancer is found in the ovaries and has spread to other body locations within the abdomen, such as the surface of the liver, intestine (bowel), or lymph nodes. The cancer has not spread to sites outside the abdomen or inside the liver.
  • Stage IV - cancer is found in the ovaries and has spread outside the abdomen or inside of the liver.
  • Recurrent or refractory - recurrent disease means that the cancer has returned (recurred) after it has been treated. Refractory disease means the cancer is no longer responding to specific types of treatment.
This content was last modified on July 23, 2007 .
Latest Ovarian Cancer News
Australian scientists plan to regrow breasts after cancer

November 12, 2009 — SYDNEY (Reuters) - Australian scientists have developed a surgical technique that may allow cancer-suffering women to regrow their breasts after having a mastectomy, with human trials planned to start within three to six months.

Hormone therapy may up risk of dying of lung cancer

September 21, 2009 — NEW YORK (Reuters Health) - Among women who already have lung cancer, hormone replacement therapy - which has been tied to a higher risk of serious conditions including breast cancer and heart attacks - seems to increase the risk of death from the tumor, according to a new study.

New pill shows promise in hard-to-treat cancers

September 3, 2009 — CHICAGO (Reuters) - An experimental cancer pill shrank tumors in patients whose skin cancer had spread, raising hope for a new class of drugs that may have an affect on many other cancers as well, U.S. researchers said on Wednesday.

Select news items provided by Reuters Health